Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,293.40    -18.00 (-1.37%)
Bid:
1,293.60
Ask:
1,294.00
Spread: 0.40 (0.031%)
Market Cap: £221.79b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Pre Stabilisation Notice

15 May 2025 13:07

RNS Number : 8771I
HSBC Bank plc
15 May 2025
Β 

15th May 2025

Β 

HSBC Holdings plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer/Trustee:

HSBC Holdings plc

Guarantor:

NA

Aggregate nominal amount:

GBP Benchmark

Description:

Fixed due 22ND May 2033

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

15th May 2025

Stabilisation period expected to end no later than:

20th June 2025

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

Β 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

Β 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

Β 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

Β 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involvedΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STAGZGMKZKKGKZM
Date   Source Headline
25th Feb 20257:00 amRNSIssuance of contingent convertible securities
24th Feb 20255:48 pmRNSTransaction in Own Shares
24th Feb 20254:30 pmRNSDirector/PDMR Shareholding
21st Feb 20255:45 pmRNSTransaction in Own Shares
21st Feb 20254:45 pmRNSPublication of base prospectus supplement
21st Feb 20254:30 pmRNSDocuments Available at NSM
20th Feb 202511:00 amRNSHSBC Holdings plc – Share buy-back
19th Feb 20254:30 pmRNSDocuments Available at NSM
19th Feb 20257:00 amRNSChange in tier 2 & MREL recognition of securities
19th Feb 20257:00 amRNSAnnual Results 2024 Zoom Meeting
19th Feb 20257:00 amRNSHSBC Holdings 2024 Results
18th Feb 20254:20 pmRNSTotal Voting Rights
13th Feb 20257:00 amRNSHolding(s) in Company
12th Feb 20253:30 pmRNSTotal Voting Rights
11th Feb 20253:30 pmRNSTransaction in Own Shares
10th Feb 20254:10 pmRNSTransaction in Own Shares
7th Feb 20254:01 pmRNSTransaction in Own Shares
7th Feb 20253:45 pmRNSNotice of redemption
7th Feb 20259:30 amRNSOverseas Regulatory Announcement - Board Meeting
6th Feb 20254:20 pmRNSTransaction in Own Shares
5th Feb 20254:30 pmRNSTransaction in Own Shares
4th Feb 20254:01 pmRNSTransaction in Own Shares
3rd Feb 20254:18 pmRNSTransaction in Own Shares
31st Jan 20253:00 pmRNSTotal Voting Rights
30th Jan 202510:00 amRNSNotice of redemption
28th Jan 20254:10 pmRNSTransaction in Own Shares
28th Jan 20253:00 pmRNSDirector/PDMR Shareholding
27th Jan 20254:10 pmRNSTransaction in Own Shares
24th Jan 20254:27 pmRNSTransaction in Own Shares
23rd Jan 20254:12 pmRNSTransaction in Own Shares
22nd Jan 20254:10 pmRNSTransaction in Own Shares
21st Jan 20254:09 pmRNSTransaction in Own Shares
20th Jan 20254:12 pmRNSTransaction in Own Shares
17th Jan 20255:30 pmRNSTransaction in Own Shares
16th Jan 20255:15 pmRNSTransaction in Own Shares
15th Jan 20255:32 pmRNSTransaction in Own Shares
14th Jan 20255:28 pmRNSTransaction in Own Shares
13th Jan 20255:19 pmRNSTransaction in Own Shares
13th Jan 202512:00 pmRNSOverseas Regulatory Announcement - Grant of Awards
10th Jan 20255:50 pmRNSTransaction in Own Shares
9th Jan 20255:13 pmRNSTransaction in Own Shares
8th Jan 20255:18 pmRNSTransaction in Own Shares
7th Jan 20255:22 pmRNSTransaction in Own Shares
7th Jan 202510:00 amRNSCompany Information Sheet
6th Jan 20255:17 pmRNSTransaction in Own Shares
3rd Jan 20255:14 pmRNSTransaction in Own Shares
3rd Jan 20254:00 pmRNSBlock listing Interim Review
2nd Jan 20255:20 pmRNSTransaction in Own Shares
31st Dec 20241:09 pmRNSTransaction in Own Shares
31st Dec 202412:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.